The utility of needle bleb revision with bevacizumab in a patient with a failing bleb following trabeculectomy is explored. The patient had previously failed needle bleb revision with mitomycin C. After needling and injection of 1 mg of bevacizumab, the bleb was noted to be more diffuse with a decrease in surface neovascularization. Bevacizumab may be an effective medication for rescuing failing filtering blebs that exhibit neovascularization.
|Original language||English (US)|
|Number of pages||4|
|Journal||Ophthalmic Surgery Lasers and Imaging|
|State||Published - Mar 1 2006|
ASJC Scopus subject areas